(Q43034442)

12 November 2017

0 references

Unique challenges faced by the clinical evaluation of dengue vaccines (English)

1 reference

12 November 2017

0 references

Robert Edelman

1

1 reference

12 November 2017

publication date

1 February 2011

1 reference

Expert Review of Vaccines

12 November 2017

published in

1 reference

12 November 2017

volume

10

1 reference

12 November 2017

issue

2

1 reference

12 November 2017

page(s)

133-136

1 reference

Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.159

Spectrum of disease and relation to place of exposure among ill returned travelers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.159

Policymakers’ views on dengue fever/dengue haemorrhagic fever and the need for dengue vaccines in four southeast Asian countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.159

Review on flavivirus vaccine development. Proceedings of a meeting jointly organised by the World Health Organization and the Thai Ministry of Public Health, 26-27 April 2004, Bangkok, Thailand

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.159

Dengue vaccine trial guidelines and role of large-scale, post proof-of-concept demonstration projects in bringing a dengue vaccine to use in dengue endemic areas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.159

Pathogenesis of dengue: challenges to molecular biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.159

Vascular leakage in severe dengue virus infections: a potential role for the nonstructural viral protein NS1 and complement

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.159

Evaluation by flow cytometry of antibody-dependent enhancement (ADE) of dengue infection by sera from Thai children immunized with a live-attenuated tetravalent dengue vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.159

Scientific consultation on immunological correlates of protection induced by dengue vaccines report from a meeting held at the World Health Organization 17-18 November 2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.159

Interference between strains in live virus vaccines. II: Combined vaccination with varicella and measles-mumps-rubella vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.159

Immunogenicity and safety of two live-attenuated tetravalent dengue vaccine formulations in healthy Australian adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.159

A novel tetravalent dengue vaccine is well tolerated and immunogenic against all 4 serotypes in flavivirus-naive adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.159

Phase 2 clinical trial of three formulations of tetravalent live-attenuated dengue vaccine in flavivirus-naïve adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.159

Enhanced severity of secondary dengue-2 infections: death rates in 1981 and 1997 Cuban outbreaks

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.159

"Guidelines for the clinical evaluation of dengue vaccines in endemic areas": summary of a World Health Organization Technical Consultation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.159

Safety and efficacy of chimeric yellow Fever-dengue virus tetravalent vaccine formulations in nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.159

Points to consider in the development of a surrogate for efficacy of novel Japanese encephalitis virus vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.159

Relationship of preexisting dengue virus (DV) neutralizing antibody levels to viremia and severity of disease in a prospective cohort study of DV infection in Thailand

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.159

Research on dengue during World War II

21 January 2018

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.4269/AJTMH.1952.1.30

Identifiers

DOI

10.1586/ERV.10.159

1 reference

12 November 2017

1 reference